0.177
Nls Pharmaceutics Ltd Borsa (NLSP) Ultime notizie
Market Update: NLS Pharmaceutics Ltd (NLSP) Sees Negative Movement, Closing at 0.17 – DWinneX - The Dwinnex
The Dwinnex
NLS Pharmaceutics Calls Shareholders' Meeting - TipRanks.com - TipRanks
TipRanks
NLS Pharmaceutics granted Nasdaq compliance extension By Investing.com - Investing.com
Investing.com
Truist maintains buy on FTI Consulting stock with $255 PT, cites growth catalysts By Investing.com - Investing.com
Investing.com
Vishay shares hold steady with revamped strategic direction By Investing.com - Investing.com
Investing.com
Vericel shares hold Buy rating on strong growth outlook By Investing.com - Investing.com
Investing.com
Truist questions Street's estimates on Celsius Holdings, initiates stock with hold By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Receives Nasdaq Compliance Extension - TipRanks.com - TipRanks
TipRanks
Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements - StockTitan
StockTitan
Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements - StockTitan
StockTitan
Entrada Therapeutics secures $100 million in direct offering By Investing.com - Investing.com Canada
Investing.com Canada
How to interpret NLS Pharmaceutics Ltd (NLSP)'s stock chart patterns – US Post News - US Post News
US Post News
Bioventus CFO sells over $80k in company stock By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Ltd's Market Journey: Closing Weak at 0.19, Down -30.80 – DWinneX - The Dwinnex
The Dwinnex
Navigating Bull and Bear Penny Stocks Markets, 3 Tips
PennyStocks
NLS Pharmaceutics AG ($NLSP) Unveiling a New Frontier in CNS Disorder Treatments with Innovative Dual Orexin ... - BP Journal
BP Journal
US Stocks Mixed; Retail Sales Increase 0.1% In May - Reliance Global Group (NASDAQ:RELI) - Benzinga
Benzinga
Why Is Aerwins Technologies (AWIN) Stock Down 54% Today? - InvestorPlace
InvestorPlace
Why Is Actelis Networks (ASNS) Stock Up 144% Today? - InvestorPlace
InvestorPlace
Why Is NLS Pharmaceutics (NLSP) Stock Up 163% Today? - InvestorPlace
InvestorPlace
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - InvestorPlace
InvestorPlace
NLS Pharmaceutics Ltd (NLSP) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
The InvestChronicle
How Do Things Look For NLS Pharmaceutics Ltd (NASDAQ: NLSP) In The Short-Term? – Stocks Register - Stocks Register
Stocks Register
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Chegg (NYSE:CHGG) - Benzinga
Benzinga
NLS Pharmaceutics Ltd (NLSP)'s highs and lows: A closer look at its stock price fluctuations – US Post News - US Post News
US Post News
Beyond Air names new Chief Commercial Officer By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Secures Patent for Dual Orexin Receptor Agonists - Sleep Review
Sleep Review
NLS Pharmaceutics Ltd (NLSP) Stock: A Year of Market Fluctuations - The InvestChronicle
The InvestChronicle
NLS Pharmaceutics announces new patent application for sleep disorder therapy By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics announces new patent application for sleep disorder therapy By Investing.com - Investing.com UK
Investing.com UK
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin ... - StockTitan
StockTitan
NLS Pharmaceutics announces new patent application for sleep disorder therapy By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Calls Shareholders' Meeting - TipRanks.com - TipRanks
TipRanks
NLS Pharmaceutics Ltd (NLSP) Stock: A Year of Highs and Lows - The InvestChronicle
The InvestChronicle
Closing Bell Recap: NLS Pharmaceutics Ltd (NLSP) Ends at 0.14, Reflecting a -15.16 Downturn – DWinneX - The Dwinnex
The Dwinnex
NLS Pharmaceutics Announces CMO Resignation - TipRanks.com - TipRanks
TipRanks
NLS Pharmaceutics Ltd (NLSP) deserves deeper analysis – US Post News - US Post News
US Post News
Deeper Dive: Understanding NLS Pharmaceutics Ltd (NLSP) Through its Various Ratios – DWinneX - The Dwinnex
The Dwinnex
Deeper Dive: Understanding NLS Pharmaceutics Ltd (NLSP) Through its Various Ratios – DWinneX - The Dwinnex
The Dwinnex
NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Up 182.0% in May - Defense World
Defense World
NLS reports narcolepsy treatment progress at ASCP By Investing.com - Investing.com
Investing.com
Mazindol Shows Neuroprotective Benefits in Narcolepsy Treatment - Sleep Review
Sleep Review
NLS Pharmaceutics Ltd Inc. (NLSP) Price Performance: A Technical Analysis Perspective - The InvestChronicle
The InvestChronicle
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol's Neuroprotective Effects in Narcoleptic ... - Yahoo Finance
Yahoo Finance
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol's Neuroprotective Effects in Narcoleptic ... - Yahoo Finance
Yahoo Finance
NLS Pharmaceutics faces potential Nasdaq delisting By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq - Yahoo Finance
Yahoo Finance
NLS Pharmaceutics Ltd (NLSP) Recovers 53.41% From Low: Sitting In The Catbird Seat? – Stocks Register - Stocks Register
Stocks Register
NLS Pharmaceutics faces potential Nasdaq delisting By Investing.com - Investing.com
Investing.com
NLS Pharmaceutics Ltd (NLSP)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex
The Dwinnex
Capitalizzazione:
|
Volume (24 ore):